Patients characteristics.

a<p>The Sokal score was known for 48 patients/72.</p>b<p>The number of patients achieving or not a major molecular response (MMR) is shown. MMR was defined as a BCR-ABL/ABL ratio ≤ 0.1% on the international scale.</p>c<p>The number of patients for whom one (or several) additional cytogenetic anomaly(ies) was (were) detected in Ph+ mitosis.</p>d<p>The number of patients who underwent either the acceleration or blastic phase at least once during the study.